UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical infectious diseases, ISSN 1058-4838, 10/2012, Volume 55, Issue 7, pp. 943 - 950
Health outcomes | Microbial sensitivity tests | Infectious diseases | Antimicrobials | Mortality | Septic shock | Infections | ARTICLES AND COMMENTARIES | Carbapenems | Klebsiella pneumoniae | Blood | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Bacterial diseases | Human bacterial diseases | Bacterial sepsis | Klebsiella pneumoniae - isolation & purification | Prognosis | Humans | Middle Aged | Bacteremia - mortality | Male | Bacterial Proteins - secretion | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Adult | Female | Retrospective Studies | Severity of Illness Index | Risk Factors | Decision Support Techniques | Bacteremia - diagnosis | Klebsiella Infections - microbiology | beta-Lactamases - secretion | Drug Therapy, Combination - methods | Klebsiella pneumoniae - enzymology | Survival Analysis | Klebsiella Infections - diagnosis | Italy | Klebsiella Infections - mortality | Aged | Cohort Studies | Klebsiella infections | Blood-borne diseases | Patient outcomes | Dosage and administration | Research | Drug therapy, Combination | Drug therapy | Bacterial infections | Gram-negative bacteria | Clinical outcomes | Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2016, Volume 17, Issue 2, pp. 153 - 163
Infectious Disease | RESISTANCE | HOSPITALS | KPC-3 | OUTBREAK | SUSCEPTIBILITY | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Klebsiella pneumoniae - isolation & purification | Escherichia coli - enzymology | Prevalence | Prospective Studies | Europe | Humans | Escherichia coli Infections - microbiology | Klebsiella Infections - microbiology | Bacterial Proteins | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Klebsiella Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Klebsiella pneumoniae - enzymology | Klebsiella pneumoniae - genetics | beta-Lactamases | Surveys and Questionnaires | Anti-Bacterial Agents - pharmacology | Surveys | Pneumonia | Bacterial pneumonia | Escherichia coli | Genomics | Cross infection | Nosocomial infections | Epidemiology | Studies | Quality standards | Surveillance | Antibiotics | E coli | Laboratories | Population | Infections | Drug resistance | Patients | Index Medicus | Medicin och hälsovetenskap
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 8/2011, Volume 53, Issue 4, pp. 373 - 376
BRIEF REPORT | Epidemics | Intensive care units | Infectious diseases | Disease transmission | Infections | Klebsiella pneumoniae | Labor standards | Inoculum | Polymyxins | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Klebsiella pneumoniae - isolation & purification | Klebsiella pneumoniae - drug effects | Humans | Klebsiella Infections - microbiology | beta-Lactamases - biosynthesis | Microbial Sensitivity Tests | Klebsiella Infections - epidemiology | beta-Lactams - pharmacology | Colistin - pharmacology | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Klebsiella pneumoniae - enzymology | Anti-Bacterial Agents - pharmacology | Bacterial Proteins - biosynthesis | Complications and side effects | Drug resistance in microorganisms | Klebsiella infections | Colistin | Distribution | Reports | Genetic aspects | Bacterial infections | Drug resistance | Cloning | Index Medicus | Brief Reports
Journal Article
American journal of infection control, ISSN 0196-6553, 2016, Volume 44, Issue 11, pp. 1374 - 1380
Infectious Disease | Infection Control | Klebsiella pneumoniae carbapenemase | carbapenems | disease outbreaks | infection control | Klebsiella pneumoniae | Public, Environmental & Occupational Health | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Klebsiella pneumoniae - isolation & purification | Klebsiella Infections - prevention & control | Global Health | Cross Infection - prevention & control | Humans | Bacterial Proteins - secretion | Klebsiella Infections - microbiology | Infection Control - methods | beta-Lactamases - secretion | Disease Transmission, Infectious - prevention & control | Klebsiella Infections - epidemiology | Disease Outbreaks | Cross Infection - microbiology | Klebsiella pneumoniae - enzymology | Cross Infection - epidemiology | Health aspects | Pneumonia | Bacterial pneumonia | Epidemics | Systematic review | Bacterial infections | Gram-negative bacteria | Disease control | Meta-analysis | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 2/2010, Volume 50, Issue 3, pp. 364 - 373
Intensive care units | Health outcomes | Microbial sensitivity tests | Antimicrobials | Hospital admissions | Hospital units | Infections | ARTICLES AND COMMENTARIES | Carbapenems | Klebsiella pneumoniae | Bacteremia | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Klebsiella pneumoniae - isolation & purification | beta-Lactam Resistance | DNA Fingerprinting | Humans | Middle Aged | Male | Klebsiella pneumoniae - classification | beta-Lactamases - biosynthesis | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Disease Outbreaks | Bacterial Typing Techniques | Aged, 80 and over | Adult | Female | Intensive Care Units | Klebsiella Infections - drug therapy | Hospitals, University | Treatment Outcome | Greece - epidemiology | Klebsiella Infections - microbiology | Electrophoresis, Gel, Pulsed-Field | Molecular Epidemiology | Klebsiella pneumoniae - enzymology | Aged | Bacterial Proteins - biosynthesis | Index Medicus
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 05/2016, Volume 22, Issue 5, pp. 444 - 450
carbapenem-resistant Klebsiella pneumoniae strain | septic shock | KPC-Kp | Adequate source control | colistin-resistance | Septic shock | Colistin-resistance | Carbapenem-resistant Klebsiella pneumoniae strain | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella pneumoniae - isolation & purification | Prognosis | Humans | Middle Aged | Male | Bacterial Proteins - secretion | Anti-Bacterial Agents - therapeutic use | Hospitals, Teaching | Shock, Septic - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Intensive Care Units | Klebsiella Infections - drug therapy | Treatment Outcome | Klebsiella Infections - microbiology | Shock, Septic - mortality | beta-Lactamases - secretion | Shock, Septic - microbiology | Adolescent | Klebsiella pneumoniae - enzymology | Survival Analysis | Klebsiella Infections - mortality | Aged | Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 3/2013, Volume 207, Issue 5, pp. 786 - 793
Killing | Lungs | MAJOR ARTICLES AND BRIEF REPORTS | Antimicrobials | Drug interactions | Infections | Drug design | Mice | Dosage | Carbapenems | Klebsiella pneumoniae | AmpC | synergism | beta-lactamases | combined killing | pharmacodynamics | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Biological and medical sciences | Medical sciences | Bacteriology | Lung - microbiology | Klebsiella pneumoniae - isolation & purification | Pneumonia, Bacterial - microbiology | Klebsiella Infections - drug therapy | Klebsiella pneumoniae - drug effects | Microbial Viability - drug effects | Humans | Treatment Outcome | Bacterial Load | Bacterial Proteins - secretion | Klebsiella Infections - microbiology | beta-Lactamases - secretion | Microbial Sensitivity Tests | Drug Therapy, Combination - methods | Animals | Klebsiella pneumoniae - enzymology | Female | Pneumonia, Bacterial - drug therapy | Anti-Bacterial Agents - pharmacology | Anti-Bacterial Agents - administration & dosage | Disease Models, Animal | Klebsiella infections | Patient outcomes | Dosage and administration | Research | Drug therapy, Combination | Drug therapy | Antibacterial agents | Drug synergism | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 9/2011, Volume 53, Issue 6, pp. 532 - 540
Polymerase chain reaction | Nursing homes | Network analysis | Hospital admissions | Bacteria | Infections | Patient surveillance | Health care facilities | ARTICLES AND COMMENTARIES | Klebsiella pneumoniae | Enterobacteriaceae | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella pneumoniae - isolation & purification | Klebsiella pneumoniae - drug effects | Humans | Middle Aged | Male | Multilocus Sequence Typing | beta-Lactamases - biosynthesis | Cross Infection - transmission | Indiana - epidemiology | Klebsiella Infections - epidemiology | Disease Outbreaks | Bacterial Typing Techniques | Drug Resistance, Multiple, Bacterial | Klebsiella pneumoniae - genetics | Aged, 80 and over | Female | Klebsiella Infections - transmission | Cross Infection - epidemiology | Klebsiella Infections - drug therapy | Klebsiella Infections - microbiology | Cross Infection - drug therapy | Contact Tracing | Illinois - epidemiology | Molecular Epidemiology | Cross Infection - microbiology | Klebsiella pneumoniae - enzymology | Aged | Bacterial Proteins - biosynthesis | Klebsiella infections | Enterobacteriaceae infections | Cross infection | Research | Nosocomial infections | Distribution | Epidemics | Hospitalization | Gram-negative bacteria | Drug resistance | Epidemiology | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 3/2013, Volume 56, Issue 5, pp. 697 - 700
Intensive care units | Antibiotics | Antimicrobials | Mortality | Sepsis | Septic shock | Urinary tract infections | Infections | Carbapenems | Klebsiella pneumoniae | BRIEF REPORTS | intensive care unit | outcome | KPC-producing Klebsiella pneumoniae | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Intensive Care Units | Klebsiella Infections - drug therapy | Gentamicins - therapeutic use | Humans | Middle Aged | Minocycline - analogs & derivatives | Male | Treatment Outcome | Klebsiella Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Carbapenems - therapeutic use | Minocycline - therapeutic use | Klebsiella pneumoniae - enzymology | Adult | Bacterial Proteins - metabolism | Colistin - therapeutic use | Female | Aged | Retrospective Studies | beta-Lactamases - metabolism | Drug Therapy, Combination | Klebsiella | Pneumonia | Critically ill | Bacterial pneumonia | Drug therapy | Health aspects | Intensive care | Gram-negative bacteria | Nosocomial infections | Index Medicus
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 08/2011, Volume 17, Issue 8, pp. 1135 - 1141
carbapenems | Klebsiella pneumoniae | Carbapenemases | KPC and VIM β-lactamases | therapeutic efficacy | KPC and VIM β‐lactamases | Therapeutic efficacy | Carbapenems | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella Infections - drug therapy | Klebsiella pneumoniae - drug effects | Humans | Treatment Outcome | Klebsiella Infections - microbiology | beta-Lactamases - biosynthesis | Anti-Bacterial Agents - therapeutic use | Animals | Carbapenems - pharmacology | Microbial Sensitivity Tests - standards | Carbapenems - therapeutic use | Klebsiella pneumoniae - enzymology | Anti-Bacterial Agents - pharmacology | Bacterial Proteins - biosynthesis | Mice | Drug Therapy, Combination | Beta lactamases | Pneumonia | Drug resistance | Bacterial pneumonia | Drug therapy | Infections | Index Medicus | Drugs | Infection | Breakpoints | Pharmacodynamics | Antibiotics | Decision making | Minimum inhibitory concentration | Data processing | Pharmacokinetics
Journal Article